Edgestream Partners »

Recursion Pharmaceuticals shares owned by Edgestream Partners

Quarter-by-quarter ownership of Recursion Pharmaceuticals (RXRX) shares owned by Edgestream Partners from 13F filings

Historical chart of Edgestream Partners investment in Recursion Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Recursion Pharmaceuticals held by Edgestream Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Recursion Pharmaceuticals by Edgestream Partners

Quarter filed Position value Share count Share price at filing
2024-03-31 $350k 35k 9.97

More positions owned by Edgestream Partners

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Meta Platforms Cl A (META)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Apple (AAPL)
McKesson Corporation (MCK)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
AmerisourceBergen (COR)
Phillips Edison & Co Common Stock (PECO)
Republic Services (RSG)
Targa Res Corp (TRGP)
Bellring Brands Common Stock (BRBR)
Ishares Tr Core S&p500 Etf (IVV)

View all positions for Edgestream Partners

Top funds holding Recursion Pharmaceuticals

ARK Investment Management
Baillie Gifford & Co
Vanguard Group
Mubadala Investment Co PJSC
BlackRock
Kinnevik AB
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
FMR
MIC Capital Management UK
Nvidia Corp
Geode Capital Management
Exor Investments
Dimensional Fund Advisors
Morgan Stanley

View all funds holding Recursion Pharmaceuticals